Wound Care Innovations acquires BioPharma Management Technologies

Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., has acquired BioPharma Management Technologies, Inc., a developer of topical pain management products. Both the companies are based in the US.

Wound Management is a provider of collagen-based wound care products to healthcare providers such as physicians, clinics, and hospitals.

Under the terms of the agreement, BioPharma Management is now a wholly owned subsidiary of Wound Management in exchange for 4.5 million shares of Wound Management's common stock.

Update on June 16, 2009:

Wound Care has reached an agreement in principle to acquire BioPharma Management.

The transaction would be structured as a share exchange pursuant to which BioPharma Management would become a wholly-owned subsidiary of Wound Management in exchange for 5 million shares of Wound Management common stock.

Announcement (December 11, 2008):

Wound Management is planning to acquire BioPharma Management.

Deal Value (US$ Million) 12.38
Deal Type                Acquisition
Sub-Category             Majority Acquisition
Deal Status              Completed: 2009-09-17

Deal Participants

Target (Company)   BioPharma Management Technologies, Inc.
Acquirer (Company) Wound Care Innovations, LLC

Deal Rationale

The acquisition would expand Wound Management's product portfolio and create market synergies with its current products.

Related terms: acquisition, healthcare, market, physicians, products, technology